查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1758788

GABA补充剂的全球市场

GABA Supplements
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 279 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球 GABA 补充剂市场规模将达到 6,080 万美元

全球GABA补充剂市场规模预计在2024年为4,550万美元，预计到2030年将达到6,080万美元，2024年至2030年的复合年增长率为4.9%。胶囊是本报告分析的细分市场之一，预计其复合年增长率为5.4%，到分析期结束时市场规模将达到2950万美元。锭剂细分市场在分析期间的复合年增长率预计为5.5%。

美国市场规模估计为 1,240 万美元，中国市场预计复合年增长率为 9.0%

美国GABA 补充剂市场规模预计在 2024 年达到 1,240 万美元。作为世界第二大经济体，中国市场规模预计在 2030 年达到 1,280 万美元，2024 年至 2030 年的复合年增长率为 9.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 2.0% 和 3.9%。在欧洲，预计德国的复合年增长率为 2.9%。

全球「GABA 补充剂」市场—主要趋势和驱动因素摘要

「GABA 补充剂」在註重健康的消费者中越来越受欢迎的原因是什么？

近年来，随着消费者对心理健康、压力管理和整体健康意识的不断增强，γ-氨基丁酸 (GABA) 补充剂的吸引力日益增强。 GABA 最初由临床神经科学界理解，作为一种天然存在的神经传导物质，如今已成为主流的健康术语。作为一种中枢神经系统抑制剂，GABA 可以促进放鬆并降低神经元兴奋性，这通常与改善睡眠品质、减轻焦虑和平衡情绪有关。对非药物干预的压力和失眠的需求激增，使 GABA 补充剂成为人们关注的焦点，尤其是在北美和欧洲。千禧世代和 Z 世代正在转向 GABA 等适应原和情绪增强剂，以增强他们在高压力环境和社交媒体影响下的情绪恢復能力。同时，电商平台和健康达人正在透过透明的标籤和临床检验进一步提高产品知名度，并建立消费者信任。随着人们对心理健康的认识逐渐降低，对安全、非处方心理健康产品的需求持续稳定成长。

为什么会出现配方和交付模式的创新？

随着配方和给药方式的创新，GABA 补充剂市场正在重塑，为製造商和消费者创造新的价值提案。从传统的胶囊和锭剂转向用户友好的形式，包括软糖、发泡粉和舌下喷雾剂，这提高了依从性，并吸引了更广泛的人群。各大品牌还将 GABA 与 L-茶氨酸、镁、褪黑激素和 5-HTP 等互补成分相结合，以创建旨在整体缓解压力和改善睡眠的协同混合物。纯素、无麸质和非基因改造配方的流行反映了消费者寻求洁净标示产品的更广泛趋势。微胶囊化和奈米递送系统等技术进步正被用于提高生物利用度和稳定性，解决人们对 GABA血脑障壁渗透性的长期担忧。此外，自有品牌和名人支持品牌的扩张正在透过推出美观且注重生活方式的产品来颠覆传统的补充剂等级制度。这种创新不再局限于药局和保健品商店，而是透过线上保健精品店和订阅模式成为主流。

哪些人口统计和分销管道将推动市场发展？

GABA 补充剂的消费不再局限于注重健康的小众群体，而是渗透到了各个年龄层和生活方式的人群中。由于学业和职场压力不断增加，年轻的专业和学生仍然是主要使用者，但老年人也对 GABA 表现出兴趣，因为它有助于睡眠，并在认知健康方面发挥潜在作用。以女性为中心的健康品牌在女性群体中获得了强有力的支持，其针对性配方可以解决与经前症候群相关的情绪波动和更年期压力。从地区来看，北美占据领先市场占有率，而亚太地区的采用率则激增，尤其是在日本、南美和印度的都市区。虽然药局、保健食品店和专业营养品商店仍然是重要的分销管道，但在以健康为重点的内容行销和网红代言的推动下，电子商务的爆炸式增长正在树立新的标竿。数位平台透过人工智慧建议提高了产品知名度、直接面向消费者的互动和客製化，重塑了消费者探索和购买 GABA 补充剂的方式。

有几个因素推动了 GABA 补充剂市场的成长。

GABA 补充剂市场的成长受到多种因素的推动，包括不断变化的消费者健康优先事项、产品创新以及数位零售转型。主要驱动因素之一是全球焦虑、失眠和压力相关疾病的增多，这推动了对安全天然情绪稳定剂的需求。其次，膳食补充剂作为合法健康干预措施的接受度日益提高（尤其是在法律规范健全的地区），这提振了消费者信心和零售商库存。第三，融合健身、正念和补充剂的混合健康方案的兴起，为 GABA 产品创造了肥沃的土壤。此外，透过口味创新、针对特定年龄的配方和个人化演算法实现的产品多样化，正在吸引新的消费群体。医疗保健支出和可支配收入的增加也支撑了市场成长，尤其是在重视预防性保健的新兴国家。此外，支持 GABA 补充剂功效的临床研究正在鼓励从业者和消费者将这些产品纳入他们的日常生活中，从而维持长期需求。

部分

剂型（胶囊、锭剂、粉剂、软糖）；分销通路（网路通路、药局分销通路、超级市场/大卖场、其他通路）

受访公司范例（值得关注的36家公司）

  • Amazing Nutrition
  • Aurobindo Pharma
  • Bloomage Biotech
  • Bluebonnet Nutrition
  • Country Life
  • Doctor's Best
  • Douglas Laboratories
  • Enzymatic Therapy
  • Garden of Life
  • Guangdong Luckerkong Biotech
  • Horbaach
  • Integrative Therapeutics
  • Jarrow Formulas
  • Klaire Labs
  • Kyowa Hakko
  • Life Extension
  • Natrol
  • Nature's Truth
  • NOW Foods
  • NutraBio

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP36968

Global GABA Supplements Market to Reach US$60.8 Million by 2030

The global market for GABA Supplements estimated at US$45.5 Million in the year 2024, is expected to reach US$60.8 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$29.5 Million by the end of the analysis period. Growth in the Lozenges Form segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.4 Million While China is Forecast to Grow at 9.0% CAGR

The GABA Supplements market in the U.S. is estimated at US$12.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.8 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global "GABA Supplements" Market - Key Trends & Drivers Summarized

What Fuels the Rising Popularity of GABA Supplements Among Health-Conscious Consumers?

Gamma-Aminobutyric Acid (GABA) supplements have gained immense traction in recent years as consumer awareness around mental health, stress management, and holistic well-being continues to surge. Originally understood in clinical neuroscience circles, GABA's role as a naturally occurring neurotransmitter has now entered mainstream wellness vocabulary. As a central nervous system depressant, GABA promotes relaxation, reduces neuronal excitability, and is commonly associated with improved sleep quality, reduced anxiety, and emotional balance. A burgeoning demand for non-pharmaceutical interventions for stress and insomnia has catapulted GABA supplements into the limelight, particularly in North America and Europe. Millennials and Gen Z, driven by high-stress environments and social media influence, are turning to adaptogens and mood enhancers such as GABA to support emotional resilience. Meanwhile, e-commerce platforms and wellness influencers have further amplified product visibility, fostering consumer trust through transparent labeling and clinical validation. As mental health becomes destigmatized, the demand for safe, over-the-counter mental wellness products continues its steady rise.

Why Are Innovations in Formulations and Delivery Formats Gaining Ground?

The GABA supplements market is being reshaped by innovation in formulations and delivery methods, creating new value propositions for manufacturers and consumers alike. From conventional capsules and tablets to gummies, effervescent powders, and sublingual sprays, the shift toward user-friendly formats is enhancing adherence and widening demographic appeal. Brands are also infusing GABA with complementary ingredients such as L-theanine, magnesium, melatonin, and 5-HTP, thereby creating synergistic blends aimed at holistic stress and sleep solutions. The popularity of vegan, gluten-free, and non-GMO formulations reflects a broader consumer trend toward clean-label products. Technological advancements such as microencapsulation and nano-delivery systems are being leveraged to increase bioavailability and stability, addressing the long-standing concern about GABA’s blood-brain barrier permeability. Additionally, private-label expansion and celebrity-backed brands are disrupting traditional supplement hierarchies by introducing high-aesthetic, lifestyle-focused offerings. These innovations are no longer limited to pharmacies and health stores but are now mainstreamed via online wellness boutiques and subscription models.

Which Demographics and Distribution Channels Are Driving Market Evolution?

GABA supplement consumption is no longer confined to niche health-focused groups but is witnessing uptake across a broad spectrum of age groups and lifestyles. While young professionals and students are primary users due to heightened academic and workplace stress, seniors are also showing increased interest in GABA for its sleep-support benefits and potential role in cognitive health. Women-centric wellness brands are crafting targeted formulations addressing PMS-related mood swings and menopausal stress, creating strong traction in female demographic segments. Geographically, while North America leads in terms of market share, Asia-Pacific is witnessing a sharp uptick in adoption, particularly in urban centers of Japan, South Korea, and India. Pharmacies, health and wellness stores, and specialty nutrition outlets remain important distribution channels; however, the explosive growth of e-commerce-powered by wellness-focused content marketing and influencer endorsements-is setting new benchmarks. Digital platforms offer greater product visibility, direct consumer engagement, and customization through AI-powered recommendations, reshaping how consumers explore and purchase GABA supplements.

The Growth in the GABA Supplements Market Is Driven by Several Factors…

The growth in the GABA supplements market is driven by several factors including evolving consumer health priorities, product innovation, and digital retail transformation. One key driver is the global uptick in anxiety, insomnia, and stress-related disorders, which has heightened demand for safe, natural mood stabilizers. Second, the increasing acceptance of nutraceuticals as a legitimate health intervention-particularly in regions with robust regulatory frameworks-is boosting both consumer confidence and retailer inventory. Third, the rise of hybrid wellness routines that combine fitness, mindfulness, and supplementation is creating a fertile ground for GABA products. Further, product diversification through flavor innovation, age-specific formulations, and personalization algorithms is attracting new consumer segments. Market growth is also supported by increasing healthcare expenditure and rising disposable incomes, especially in emerging economies where preventive wellness is gaining importance. Additionally, clinical research supporting the efficacy of GABA supplements is encouraging both practitioners and consumers to integrate these products into daily regimens, sustaining long-term demand.

SCOPE OF STUDY:

The report analyzes the GABA Supplements market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Capsules Form, Lozenges Form, Powder Form, Gummies Form); Distribution Channel (Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Amazing Nutrition
  • Aurobindo Pharma
  • Bloomage Biotech
  • Bluebonnet Nutrition
  • Country Life
  • Doctor's Best
  • Douglas Laboratories
  • Enzymatic Therapy
  • Garden of Life
  • Guangdong Luckerkong Biotech
  • Horbaach
  • Integrative Therapeutics
  • Jarrow Formulas
  • Klaire Labs
  • Kyowa Hakko
  • Life Extension
  • Natrol
  • Nature's Truth
  • NOW Foods
  • NutraBio

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • GABA Supplements - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Stress and Anxiety Disorders Spurs Demand for GABA-Based Supplements
    • Consumer Shift Toward Natural Mood Enhancers Strengthens Market for Non-Prescription Solutions
    • Rising Interest in Cognitive Wellness Expands the Addressable Market for Neuroactive Compounds
    • Product Innovation in Gummies and Functional Beverages Drives Adoption of GABA Ingredients
    • E-commerce Growth and DTC Health Brands Accelerate Access to GABA Formulations
    • Clean Label and Plant-Derived Trends Throw Spotlight on Naturally Sourced GABA Supplements
    • Regulatory Flexibility in Nutraceutical Labeling Encourages New Product Launches
    • Increased Scientific Validation of GABAs Effects Strengthens Consumer Confidence and Repeat Usage
    • Rising Popularity of Sleep Aids and Relaxation Products Propels Nighttime GABA Supplement Demand
    • Celebrity and Influencer Endorsements Amplify Market Visibility and Product Differentiation
    • Integrative Health Practices Expand Use of GABA in Holistic Wellness Programs
    • Stacking with Nootropic Formulations Generates Demand for Multi-Ingredient GABA Products
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World GABA Supplements Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for GABA Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Capsules Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Capsules Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Capsules Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lozenges Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Lozenges Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Lozenges Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Powder Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gummies Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gummies Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Gummies Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Supermarkets / Hypermarkets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Supermarkets / Hypermarkets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Supermarkets / Hypermarkets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • JAPAN
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CHINA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • EUROPE
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for GABA Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • FRANCE
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • GERMANY
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for GABA Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • INDIA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for GABA Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for GABA Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AFRICA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030

IV. COMPETITION